http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-295548-A5

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_313c2ac1c6159e38a96bd17d83b17a2b
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
filingDate 1987-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e620162cfdaabf32e3a098fb8ebd06c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72e0866e4f63244c7ad6a7fa158cc0ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a00352837e2e3a6a342b5ed8515e416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73ca1fa294c8739ca18b365b006b255c
publicationDate 1991-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DD-295548-A5
titleOfInvention METHOD FOR PRODUCING A MORPHINE MEDICAMENT WITH A SIMILARLY DELAYED ACTIVE INGREDIENT EXTRACTION
abstract The invention relates to a method for producing a perorally administrable sustained-release pharmaceutical formulation of morphine, in which the active ingredient is embedded in a hydrophilic matrix consisting of a mixture of polyvinyl alcohols having different vinyl acetate content and non-toxic adjuvants; it contributes significantly to the improvement of the treatment of severe and severe pain conditions, especially in cancer patients, by ensuring uniform blood levels of the active ingredient over a desired period of time, and is technologically and economically advantageous to produce {morphine; Retardarzneimittel; hydrophilic matrix; Mixture of polyvinyl alcohols; Therapy of severe and severe final pain states}
priorityDate 1987-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453865105
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5288826
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5464110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419129972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507808

Total number of triples: 22.